Skip to main content
Elizabeth Lamont, MD, Oncology, Brookline, MA

ElizabethBernierLamontMD

Oncology Brookline, MA

Founder and Chief Medical Officer Salient Care, LLC

Dr. Lamont is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lamont's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoM.S., Health Studies, 2000
  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1996 - 1998
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1993
  • Boston College
    Boston CollegeB.A., English, with Honors, 1989

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2024
  • IL State Medical License
    IL State Medical License 1996 - 2005
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Certificate of Excellence In Tutoring, Among the Highest Rated Tutors by Harvard Medical Students Harvard Medical School, 2013-2014
  • Merit Award, Among Highest Ranked Fellow Abstracts ASCO, 1998, 2000
  • Janet M. Glasgow Memorial Citation, First Woman in Graduating Class (2nd Overall) Dartmouth Medical School, 1993
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)  
    Lamont EB, Schilsky RL, He Y, Muss H, Cohen H, Hurria A, Meilleur AE, Kindler HL, Venook A, Lilenbaum R, Niell H, Goldberg RM and Joffe S for the Alliance for Clinical..., J Natl Cancer Inst, 1/27/2014
  • A national study of the quality of cancer care for older cancer patients in the Veterans Health Administration versus fee-for-service Medicare  
    Keating NL, Landrum MB, Lamont EB, Bozeman SR, Krasnow SH, Shulman LN, Brown JR, Earle CC, Oh WK, Rabin M, McNeil BJ, Annals of Internal Medicine, 1/1/2011
  • Evaluating Colorectal Cancer Care in the Veterans Health Administration: How Good are the Data?  
    Lamont EB, Landrum MB, Bozeman SR, McNeil BJ, Journal of Geriatric Oncology, 1/1/2011
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Effectiveness of cisplatin vs. carboplatin doublets in elderly Medicare patients with advanced lung cancer.
    Lamont EB, Keating NL, Azzoli, CG, and Landrum MB, ASCO Quality of Care Symposium, Boston, MA, 1/17/2014
  • Effectiveness of Cisplatin vs. Carboplatin-Based Doublet Chemotherapy in Elderly Medicare Patients with Advanced Non-Small Cell Lung Cancer
    Lamont EB, American Society of Clinical Oncology Quality of Care Meeting, Boston, MA, 1/1/2014
  • Trends in chemotherapy-related treatment of late-stage colon and rectal cancer.
    C Bradley, KR Yabroff, JL Warren, N Chawley, C Zerutoc, EB Lamont, Journal of Clinical Oncology, 1/1/2013
  • Join now to see all

Lectures

  • Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Elderly breast and colorectal cancer patients' clinical course: patient and contextual influences. 
    Yorktown, NY - 1/1/2014
  • Hospital-Based Health Care Use Correlates with Incidence of Treatment-Related Adverse Events Among Elderly Medicare Patients Treated on Adjuvant Chemotherapy Trials 
    Dana-Farber/Harvard Cancer Center - 1/1/2013
  • Join now to see all

Other

Press Mentions

  • Dramatic Drop in New Cancer Drug Trials During the COVID-19 Pandemic
    Dramatic Drop in New Cancer Drug Trials During the COVID-19 PandemicFebruary 4th, 2021
  • Cancer Care Services Don't Differ by Neighborhood
    Cancer Care Services Don't Differ by NeighborhoodJanuary 29th, 2016

Grant Support

  • DO Medicare Claims Measure Cancer Relapse Patients: An External Validation StudyNational Cancer Institute2011
  • Population-Based Assessment Of Cancer Trial Generalizability In The ElderlyNational Cancer Institute2008–2011
  • Development Of Hierarchical Neighborhood Data Regarding Cancer In The ElderlyNational Institute On Aging2007–2008
  • DO Medicare Claims Measure Chemotherapy Use And OutcomesNational Cancer Institute2004–2006
  • DO Medicare Claims Measure Chemotherapy Use And OutcomesNational Cancer Institute2002–2003

Professional Memberships